Advertisement

Chromatographia

, Volume 67, Issue 5–6, pp 441–447 | Cite as

A Validated Stability-Indicating TLC Method for Determination of Forskolin in Crude Drug and Pharmaceutical Dosage Form

  • Sayeed Ahmad
  • Mohd. Rizwan
  • Rabea Parveen
  • Mohd. Mujeeb
  • Mohd. Aquil
Original

Abstract

A simple, accurate, selective, precise, economical and stability-indicating high-performance thin-layer chromatographic method for analysis of forskolin in crude drug and in pharmaceutical dosage form was developed and validated. The method was developed on TLC aluminium plates precoated with silica gel 60F-254 using solvent system benzene:methanol (9:1, v/v), which gives compact spot of forskolin (R f value 0.25 ± 0.02). Densitometric analysis of forskolin was carried out in the absorbance mode at 545 nm after spraying with anisaldehyde sulphuric acid. The linear regression analysis data for the calibration plots showed good linear relationship with r = 0.994 and 0.994 with respect to peak height and peak area, respectively, in the concentration range 100–1,000 ng per spot. The limits of detection and quantification were 8.1 and 26.9 ng per spot, respectively. The proposed method was applied for determination of forskolin in Coleus forskohlii root and in capsule dosage forms, which showed 0.18 and 0.57% w/w of forskolin. Forskolin was subjected to acid and alkali hydrolysis, oxidation, photodegradation and heat degradation. It was observed that the drug is susceptible to acid, base hydrolysis, oxidation, photo-oxidation and heat degradation. Statistical analysis proves that the method is repeatable, selective and accurate for the estimation of forskolin in crude drug and in pharmaceutical dosage forms. The developed method effectively resolved the forskolin from components of C. forskohlii root, from excipients of capsule as well as the degradation products of forskolin hence, it can be employed for routine analysis and as a stability-indicating method.

Keywords

Thin layer chromatography Validation Forskolin Coleus forskohlii 

Notes

Acknowledgments

The authors are thankful to Sami Labs Ltd., Bangalore for providing standard forskolin as a gift sample.

References

  1. 1.
    Bhat SV, Bajwa BS, Dornauer H, De Souza NJ, Fehlhaber HW (1977) Tetrahedron Lett 19:1669–1672CrossRefGoogle Scholar
  2. 2.
    Tandon JS, Dhar MM, Ramakumar S, Venkatesan K (1977) Indian J Chem 15B:880–883Google Scholar
  3. 3.
    Dubey MP, Srimal RC, Nityanand S, Dhawan BN (1981) J Ethnopharmacol 3:1–13CrossRefGoogle Scholar
  4. 4.
    Seamon KB, Daly JW (1981) J Cyclic Nucleotide Res 7:201–224Google Scholar
  5. 5.
    Wysham DG, Brotherton AF, Heistad DD (1986) Stroke 17:1299–1303Google Scholar
  6. 6.
    Marone G, Columbo M, Triggiani M (1986) Agents Actions 18:96–99CrossRefGoogle Scholar
  7. 7.
    Roger PP, Servais P, Dumont JE (1990) Exp Cell Res 172:282–292CrossRefGoogle Scholar
  8. 8.
    Allen DO, Ahmed B, Naseer K (1986) J Pharmacol Exp Ther 238:659–664Google Scholar
  9. 9.
    Lichey I, Friedrich T, Priesnitz M, Biamino G, Usinger P, Huckauf H (1984) Lancet 2:167CrossRefGoogle Scholar
  10. 10.
    Caprioli J, Sears M (1983) Lancet 1:958–960CrossRefGoogle Scholar
  11. 11.
    Dubey MP, Srimal RC, Nityanand S, Dhawan BN (1981) J Ethnopharmacol 3:1–13CrossRefGoogle Scholar
  12. 12.
    Agarwal KC, Parks RE (1983) Int J Cancer 32:801–804CrossRefGoogle Scholar
  13. 13.
    Ammon HP, Muller AB (1984) Naunyn Schmiedebergs Arch Pharmacol 326:364–367CrossRefGoogle Scholar
  14. 14.
    Wong S, Mok W, Phaneuf S, Katz S, Salari H (1993) Eur J Pharmacol 245:55–61CrossRefGoogle Scholar
  15. 15.
    Ding X, Staudinger JL (2005) J Pharmacol Exp Ther 312:849–856CrossRefGoogle Scholar
  16. 16.
    Yanagihara H, Sakata R, Shoyama Y, Murakami H (1996) Planta Med 62:169–172CrossRefGoogle Scholar
  17. 17.
    Schaneberg BT, Khan IA (2003) J AOAC Int 86:467–470Google Scholar
  18. 18.
    Bonté F, Pinguet P, Saunois A, Chevalier JM, Meybeck A (1997) J Chromatogr A 791:231–235CrossRefGoogle Scholar
  19. 19.
    Wagner H, Bladt S (1996) Plant drug Analysis: A thin layer chromatography atlas. Springer, New York, p 359Google Scholar
  20. 20.
    ICH (1994) Text on Validation of Analytical Procedures, Harmonised Tripartite Guideline prepared within the International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use, ICH-Q2A, GenevaGoogle Scholar
  21. 21.
    ICH (1996) Validation of Analytical Procedures: Methadology, Harmonised Tripartite Guideline prepared within the International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use, ICH-Q2B, GenevaGoogle Scholar
  22. 22.
    ICH (1995) Draft guidelines on validation of analytical procedures: definition and terminology, federal register, vol 60. IFPMA, SwitzerlandGoogle Scholar
  23. 23.
    ICH (2003) Stability testing of new drug substances and products (Q1AR2). In: Proceedings of the international conference on harmonization, IFPMA, GenevaGoogle Scholar
  24. 24.
    Vishwakarma RA, Tyagi BR, Ahmed B, Hussain M (1988) Planta Med 54:471–472CrossRefGoogle Scholar
  25. 25.
    Saleem AM, Dhasan PB, Rafiullah MRM (2006) J Chromatogr A 1101:313–314CrossRefGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlag/GWV Fachverlage GmbH 2008

Authors and Affiliations

  • Sayeed Ahmad
    • 1
  • Mohd. Rizwan
    • 2
  • Rabea Parveen
    • 2
  • Mohd. Mujeeb
    • 1
  • Mohd. Aquil
    • 2
  1. 1.Department of Pharmacognosy and Phytochemistry, Faculty of PharmacyHamdard UniversityNew DelhiIndia
  2. 2.Department of Pharmaceutics, Faculty of PharmacyHamdard UniversityNew DelhiIndia

Personalised recommendations